Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas"

Transcription

1 2000 Nature America, Inc /00/$15.00/ 0 Gene delivery by an epidermal growth factor/dna polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor Klaus Stensgaard Frederiksen, 1 Niels Abrahamsen, 1 Richard J. Cristiano, 2 Lars Damstrup, 1 and Hans Skovgaard Poulsen 1 1 Section of Radiation Biology, National University Hospital, Copenhagen, Denmark; and 2 Department of Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas In the present study, we wanted to determine whether efficient gene delivery using an epidermal growth factor (EGF)/DNA polyplex could be accomplished in small cell lung cancer (SCLC) cell lines expressing low EGF receptor (EGFR) levels. EGFR expression levels and transduction efficiencies with polyplexes were examined in five SCLC cell lines and two controls. EGFR expression was examined by binding assays and demonstrated low EGFR levels ranging from 3.6 to 87.4 fmol/mg protein. The SCLC cell lines exhibited high sensitivity to adenovirus infection, which was an important determinant for transduction efficiency when adenovirus was used as an endosomolytic agent. The transduction efficiencies with EGF/DNA polyplexes ranged from 41% 3.5% to 73% 4.6% in the EGFR-positive SCLC cell lines. In the controls lacking EGFRs, only 5% 1.0% and 8% 1.8% of the cells were transduced. Furthermore, the transduction efficiency could be reduced from 50% 4.9% to 18% 1.1% when excess EGF was added to compete with the EGF/DNA polyplexes. In the present study, receptor-targeted gene delivery to SCLC cell lines has been demonstrated for the first time. Our results indicate that even low receptor expression levels in the target cells are sufficient for efficient and specific in vitro gene delivery with EGF/DNA polyplexes. Cancer Gene Therapy (2000) 7, Key words: Epidermal growth factor; DNA polyplex; small cell lung cancer; targeted gene delivery; nonviral vectors. Received October 9, 1998; accepted March 6, Address correspondence and reprint requests to Dr. Hans Skovgaard Poulsen, Finsen Center, 6321, National University Hospital, 9, Blegdamsvej, DK-2100 Copenhagen Denmark. address: Small cell lung cancer (SCLC) comprises 25% of all lung cancer cases and is generally treated with different combinations of chemotherapy alone or in combination with radiotherapy. The prognosis for SCLC patients is very poor, with a 5-year survival rate that is 5%. 1 Because of this poor prognosis, there is an urgent requirement for research into the development of new therapies, such as gene therapy for SCLC. From the first clinical trials of gene therapy for cancer, the crucial importance of suitable gene delivery systems has become evident. When the malignancy is disseminated, a delivery system that can specifically target tumor cells throughout the body may be decisive for the successful application of gene therapy for advanced cancer. One way to accomplish targeted gene delivery is by the coupling of receptor-specific ligands to a plasmid containing the therapeutic gene. Gene delivery to specific cell types by receptor-mediated endocytosis of molecular conjugate vectors has been successful with a variety of different ligands, such as transferrin, 2 folate, 3 asialoorosomucoid, 4 and epidermal growth factor (EGF). 5 EGF/ DNA polyplexes consist of molecules of EGF coupled to a plasmid vector via poly-lysine bridges, which form ionic bonds to the negatively charged DNA (Fig 1). The EGF receptor (EGFR) is overexpressed in non-small cell lung cancer (NSCLC) tumors, and efficient gene delivery using EGF/DNA polyplexes has been reported previously in NSCLC cell lines. 5 In the present study, we wanted to determine whether specific and efficient gene delivery with EGF/DNA polyplexes could be accomplished in small cell lung cancer (SCLC) cell lines exhibiting low levels of EGFR expression. The EGF binding capacity was determined in different SCLC cell lines, and cell lines exhibiting different EGFR expression levels were included in EGF/ DNA polyplex transfections to determine the influence of EGFR concentration on gene delivery by EGFRmediated endocytosis. In addition, we examined the susceptibility of the SCLC cell lines to adenovirus infection. Variations in the sensitivity to adenovirus infection among the different cell lines could influence the transfection efficiency with EGF/DNA polyplexes, because replication-deficient adenovirus was used as an agent for endosomal lysis. Using EGF/DNA polyplexes, we were able to obtain highly efficient gene delivery to SCLC cell lines expressing very low levels of EGFR. This is the first 262 : pp

2 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES 263 X-100) and incubated for 30 minutes at room temperature. An aliquot of sample was applied from each tube for counting in a Wallac -counter (Turku, Finland). Protein concentration was determined for each sample using the bicinchoninic acid protein kit (Pierce Europe, BA Oud Beijerland, The Netherlands). Nonspecific binding of EGF was determined in the presence of 30,000 pm of unlabeled EGF, and the proportion of nonspecific binding was calculated for each sample. The specific binding was calculated by subtracting nonspecific binding from total binding. The free EGF in the samples was calculated as the total EGF in the sample minus the specific binding. Calculation of the dissociation constant (K d ) and the maximal EGF binding capacity (B max ) was done as described by Scatchard. 13 Figure 1. Representation of an EGF/DNA polyplex. Biotin (B)- coupled EGF and PLL (K) are initially bound to streptavidin. The positively charged poly-lysine (K) bridges form ionic bonds with the negatively charged DNA, whereby the EGF molecules are linked to the DNA. demonstration of receptor-targeted gene delivery to SCLC cell lines. Our findings may have important implications for the proper selection of target receptors for gene delivery by receptor-mediated endocytosis. MATERIALS AND METHODS Cell culture The cell lines used in the experiments were A431, 6 an epidermoid carcinoma; CPH54A, 7 GLC2, 8 DMS114, 9 DMS153, 9 and DMS456, 10,11 small cell lung carcinomas; and SW620, 12 a colon adenocarcinoma. All cell lines, except SW620, were cultured in 175-cm 2 flasks (Nalge Nunc International, Naperville, Ill) at 37 C, 5% CO 2, and 80% humidity. SW620 was cultured in 175-cm 2 flasks at 37 C in atmospheric air. The cell lines were cultured in appropriate medium (Life Technologies, Roskilde, Denmark) containing 10% fetal calf sera (FCS) (Life Technologies) without antibiotics. EGFR binding studies To obtain a quantitative analysis of the EGFR expression levels in the included cell lines, receptor binding studies using 125 I-labeled EGF were performed. Cells were harvested and washed twice in chilled binding buffer with bovine serum albumin (BSA) (128 mm NaCl, 5 mm KCl, 5 mm MgSO 4, 1.2 mm CaCl 2,50mMN-2-hydroxyethylpiperazine-N -2-ethanesulfonic acid (ph 7.2), and 2% BSA) for 30 minutes. After washing, the cells were incubated with a fixed concentration (25 or 100 pm) of 125 I-EGF (New England Nuclear, Boston, Mass) and increasing concentrations (0 30,000 pm) of nonlabeled EGF (Calbiochem, Bad Soden, Germany) in a final volume of 1 ml of binding buffer with BSA. Incubations were carried out at room temperature for 2 hours with overhead turning of tubes. After incubation, cells were washed twice with ice-cold binding buffer without BSA. After the final wash, cells were resuspended in 1 ml of solubilization buffer (128 mm NaCl, 0.25 mm ethylenediaminetetraacetic acid, 0.5 mm tris(hydroxymethyl)aminomethane (ph 7.2), and 1% Triton EGF/DNA polyplex formation The coupling of EGF to DNA was carried out in a stepwise procedure. The first steps involved the coupling of biotinylated EGF to biotinylated poly-l-lysine (PLL). EGF (Biosource International, Camarillo, Calif) and PLL (average molecular weight of 22,500; Sigma, St. Louis, Mo) were biotinylated with biotin hydroxysuccinimide ester (Pierce, Rockford, Ill) as described previously. 5 The biotinylated EGF (1.2 biotin/egf, biotin M) was added dropwise to streptavidin (0.17 M) (Pierce) with vortexing in a sterile 1.5-mL tube. After a 5-minute incubation at room temperature, the biotin-pll (4.5 biotin/pll, NH 2 30 M, biotin M) was then added dropwise to the reaction mixture with vortexing. The molar ratios between EGF and streptavidin were 1:1, and the ratios between EGF and PLL were 4.5:1. After a 5-minute incubation, the resulting EGF/PLL conjugates were mixed with the plasmid and incubated at room temperature for 30 minutes to allow for polyplex formation. In the polyplex formation, the positively charged lysines will interact with the negatively charged plasmid to form electrostatic bonds between the EGF/PLL and the plasmid (Fig 1). The polyplex solution had a final DNA amount of 10 g in 1 ml of 5 mm N-2- hydroxyethylpiperazine-n -2-ethanesulfonic acid buffer (ph 7.0). Physical characteristics such as the size, charge, and stability of the EGF/DNA polyplex have been described previously by Xu et al. 14 The EGF ligand used was modified to contain only one biotin per EGF molecule. This modification has been shown previously not to change the binding affinity of EGF. 15 Adenovirus isolation The replication-defective adenoviruses dl312 (a gift of Dr. Thomas Shenk, Princeton University, Princeton, NJ) and Ad5CMV -gal were propagated on 293 cells and purified and stored using techniques reported previously. 16,17 Viral titer was determined by ultraviolet spectrophotometric analysis. 16,17 Transfection and transduction experiments The examined cell lines were cultured in 12-well dishes (Costar, Cambridge, Mass). At the time of transduction or transfection, the cells were subconfluent. Before the addition of polyplexes to the cells, replication-defective adenovirus (dl312) was mixed with the polyplexes. The amount of added adenovirus was adjusted to equal a multiplicity of infection (MOI) of To each well, 333 L (3 g of DNA) of polyplex reaction was added as well as 500 L of cell culture medium containing 2% FCS. In transduction experiments with the adenovirus vector Ad5CMV -gal, cells were incubated

3 264 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES Figure 2. EGF binding to the SCLC cell line GLC2. A Scatchard plot of the binding data (insert) is shown. In the Scatchard plot, the maximal specific binding of EGF (B max ) is given by the x-interception (y 0). The dissociation constant K d is calculated from the slope of the curve (y ) as K d (y ) 1. with 500 L of cell culture medium containing 2% FCS and 1000 virus particles per cell. Cells were incubated for 2 hours at 37 C. After incubation, the medium was gently aspirated and 1 ml of cell culture medium containing 10% FCS was added per well. Cells were incubated at 37 C overnight. For the visualization of -galactosidase ( -gal) activity, cells were fixed and stained with 5-bromo-4-chloro-3-indolyl b-dgalactoside (Promega, Madison, Wis) staining solution. The cells were fixed for 5 minutes in cold 0.5% glutaraldehyde (Sigma). After aspiration of the fixative, cells were incubated with 1 ml of 5-bromo-4-chloro-3-indolyl b-d-galactoside staining solution per well overnight. The percentage of blue-stained cells was determined by counting the cells lying within the grid of a Leitz Wetzlar Periplan 10 ocular (Leica, Wetzlar, Germany) mounted on a reverse microscope. Cells were photographed using a Kodak digital camera (Rochester, NY). RESULTS EGFR binding studies To quantify the number of EGFRs in the SCLC cell lines and controls, binding studies using 125 I-labeled EGF were performed. Cell suspensions were incubated with a fixed concentration of 125 I-EGF and increasing concentrations of unlabeled EGF. An example of EGF binding data and a Scatchard analysis from an SCLC cell line (GLC2) are shown in Figure 2. From the Scatchard analysis of the binding data, it was determined that GLC2 expressed a mean of 87.4 fmol of EGFR per milligram of protein. The binding analysis demonstrated one high-affinity EGF binding site in all the SCLC cell lines tested. The cell lines bound between 3.6 and 87.4 fmol of EGF per milligram of protein, with a K d ranging from * M. The positive control cell line A431 bound 7829 fmol of EGF per mg of protein and had a K d of 3.57 * 10 9 M. The K d of EGF binding in A431 has been determined previously to be 5 *10 9 M. 18 The negative control SW620 showed no evidence of receptorspecific binding of EGF in two independent experiments. In our laboratory, the SCLC cell line DMS456 has been shown previously not to contain any specific EGF binding sites. 19 All the binding data are presented in Table 1. Transfection experiments with EGF/DNA polyplexes To study in vitro gene delivery by EGFR-mediated endocytosis in SCLC cells, transfection experiments using EGF/DNA polyplexes were performed in the SCLC cell lines DMS114, DMS153, DMS456, CPH54A, and GLC2. For visualization of transfection, a plasmid vector containing the Escherichia coli lacz gene under the control of the cytomegalovirus promotor/enhancer 20 was used in the transfection experiments. To avoid lysosomal degradation of internalized EGF/DNA polyplexes, a replication-deficient serotype 5 adenovirus mutant (dl312), 21 was coincubated with the EGF/DNA polyplexes. Table 1. EGF Receptor Binding in SCLC Cell Lines and Controls Cell line Mean values (B max ) Mean values (K d ) DMS fmol/mg protein 1.92 * M DMS fmol/mg protein 3.90 * M CPH54A 31.1 fmol/mg protein 2.46 * M GLC fmol/mg protein 6.78 * M DMS456 No specific binding detected A fmol/mg protein 3.57 * 10 9 M SW620 No specific binding detected

4 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES 265 In all SCLC cell lines containing EGFRs, highly efficient gene delivery was accomplished with this vector system (Fig 3, A C and E). The percentage of cells staining positive for -gal activity ranged from 41% 3.5% in GLC2 to 73% 4.6% in CPH54A (Table 2). Initially the optimum polyplex amount was found by incubating the cell lines with increasing concentrations of EGF/DNA polyplexes, and the transfection experiments were performed with the given optimum polyplex concentrations. A polyplex amount of 10 g of DNA per three wells was used in all cell lines, except for DMS114, for which the optimum polyplex concentration was found to be 8 g ofdnaper three wells. The cell lines tested were incubated with an MOI of 3 *10 3. This saturating titer has been found previously to result in efficient gene delivery in NSCLC cell lines using EGF/DNA polyplexes. 5 To study the specificity of the EGF/DNA polyplex uptake, the vector system was tested in the cell lines DMS456 and SW620, which contained no functional EGFRs. The observed transfection efficiency in SW620 was only 5% 1.0%; in DMS456 (Fig 3D), the efficiency was 10% 2.3%. Furthermore, a competition analysis was performed in DMS114 and SW620 by adding an excess of free EGF (30,000 pm) along with the EGF/ DNA complexes. In DMS114, the competition with free EGF reduced the percentage of blue cells from 50% 4.9% to 18% 1.1% (Fig 3, E F). To determine whether this reduction was due to inhibition of polyplex binding to the EGFR, competition with a nonspecific inhibitor was performed. When adding an excess of insulin (60 M), no reduction in transfection efficiency was observed. In CPH54A, the transfection efficiency could only be reduced from 73% 5.0% to 48% 12.2% in competition studies with excess EGF. The low transfection efficiencies in the EGFR-negative controls SW620 and DMS456 were not affected by excess EGF. When EGF/DNA polyplex transfections were performed without functional adenovirus, no blue-staining cells could be observed (data not shown). Transduction experiments with Ad5CMV -gal To examine the susceptibility of the included cell lines to adenovirus infection, transduction experiments with the adenovirus vector Ad5CMV -gal were prepared. Because adenovirus was used as an endosomolytic agent, we wanted to determine whether variations in cell line susceptibility to adenovirus infection could influence the transfection efficiency with EGF/DNA polyplexes. Ad5CMV -gal contains the bacterial -gal gene under the transcriptional control of the cytomegalovirus promoter. The cell lines were infected with Ad5CMV -gal at an MOI of In all of the included SCLC cell lines, a high percentage of the cells could be infected by the adenovirus vector (Table 2). The transduction efficiencies ranged from 42% 1.7% in DMS456 to 99% 0.5% in DMS153. Somewhat lower transduction efficiencies were observed in the control cell lines SW620 and especially A431 (Table 2). In SW620, 27% 9.0% of the cells stained blue, but in A431 the transduction efficiency was only 3% 0.8%. DISCUSSION The evolution of vector systems that specifically target disseminated tumor cells throughout the body has evolved to be one of the major issues concerning the development of gene therapy for advanced cancer. In the present study, important aspects of targeted gene delivery to SCLC through ligand-receptor interactions have been examined. In the first part of the study, we wanted to examine the influence of cellular EGFR expression levels on the transfection efficiency using EGF/DNA polyplexes. Initially the EGFR expression was examined in the included SCLC and control cell lines by binding assays using 125 I-EGF. The SCLC cell lines DMS114, DMS153, CPH54A, and GLC2 all exhibited receptor-specific binding of EGF. These cell lines represented four different levels of EGFR expression, with mean B max values ranging from 3.6 fmol/mg protein in DMS114 to 87.4 fmol per milligram of protein in GLC2 (Table 1). The B max and K d values for EGF binding in the SCLC cell lines were similar to previously published findings of EGFR expression in SCLC cell lines. 19,22 The determined levels of EGFR expression are low compared with NSCLC cell lines. In a study of the EGFR expression in nine NSCLC cell lines, the mean B max for EGF binding was 505 fmol per milligram of protein. 22 The transfection experiments with EGF/DNA polyplexes showed that the observed low levels of EGFR expression were sufficient for highly efficient in vitro gene delivery to SCLC cells (Table 2). The transfection efficiency of 52% 2.1% in DMS114 only expressing 3.6 fmol of EGFR per milligram of protein emphasized this conclusion especially. This finding, together with the observed transfection efficiency of 35% 12.1% in the positive control A431, expressing 7829 fmol of EGFR per milligram of protein, strongly indicates that overexpression of a target receptor is not a prerequisite for efficient gene delivery with complexes of ligand/dna. Furthermore, it stresses the importance of a restricted expression of the target receptor to the target tissue, because even low receptor expression in nontarget tissues may be sufficient for undesirable gene delivery to these tissues. These conclusions may have important implications for the proper selection of suitable target receptors for gene delivery by receptor-mediated internalization. To test that the EGF/DNA polyplex uptake occurred specifically through the EGFR, transfection experiments were performed in the cell lines SW620 and DMS456, which has no specific EGF binding. Only 5% 1.0% and 10% 2.3% of the cells in SW620 and DMS456, respectively, stained positive for -gal activity after transfection with EGF/DNA polyplexes. In comparison with the transfection efficiencies accomplished in the

5 266 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES Figure 3. EGF/DNA polyplex-transduced in vitro-cultured cell lines (A F) stained for -gal activity. CPH54A (A), DMS153 (B), GLC2 (C), DMS456 (D), DMS114 (E), all without competition, and DMS114 with 30 M of EGF competition (F). Also see Table 2. EGFR-positive SCLC cell lines, these results indicate that the uptake of EGF/DNA polyplexes is specifically mediated through the EGFR. Nonspecific interactions between the adenovirus and the EGF/DNA polyplex, which could form conjugates available for internalization through the Coxsackie adenovirus receptor (CAR), may explain the low levels of nonspecific transfection in SW620 and DMS456. To further investigate the uptake of EGF/DNA polyplexes, competition studies adding excess free EGF were performed. In SW620 and DMS456, the competition with free EGF did not influence the transfection effi-

6 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES 267 Table 2. Transfection Efficiencies in Tested Cell Lines Cell line EGF/DNA polyplexes (percentage of blue cells) Ad5CMV -gal virus (percentage of blue cells) CPH54A 73% 4.6% 94% 2.1% DMS114 52% 2.1% 88% 1.0% DMS153 48% 1.5% 99% 0.5% DMS456 10% 2.3% 42% 1.7% GLC2 41% 3.5% 44% 3.8% A431 35% 12.1% 3% 0.8% SW620 5% 1.0% 27% 9.0% ciency, which confirms that the observed transfections in these cell lines were nonspecific. In the SCLC cell lines DMS114 and CPH54A, the percentage of positive staining cells were reduced in competition studies with excess EGF. This indicates that the gene delivery occurs through the EGFR. The differences between the observed transfection efficiencies in the SCLC cell lines seems to be due to factors other than the different B max and K d values for EGF binding. Recalling that the reciprocal of K d expresses the affinity of the receptor binding, it could be postulated that the high K d value of A431, at least in part, could account for the relatively low transfection efficiency found in this cell line. A431 has been shown previously to contain both high- and low-affinity EGF binding sites. 18 Approximately % of the EGFRs in A431 are high-affinity receptors with a K d of 7 * M. Nevertheless, other factors such as differences in the sensitivity to the agent for endosomal lysis (i.e., adenovirus dl312) could also contribute to the observed disparities in the transfection efficiencies. It is generally assumed that the presence of the adenovirus particle in the endosome compartment containing an internalized ligand/dna polyplex is dependent upon the binding of the adenovirus to its own receptor (i.e., the CAR). 23 When cells are incubated with polyplexes of ligand/dna and adenovirus, both polyplexes and virus particles will initially bind to their receptors on the cell surface. A fraction of the receptorbound adenovirus and ligand/dna is internalized in the same endosome, and only DNA from these endosomes will escape lysosomal degradation. 23 Therefore, differences in the expression levels of CAR could be a very important determinant for the efficiency of gene delivery with EGF/DNA polyplexes in the present study. Furthermore, differences in the levels of integrin v 5 may also influence the adenovirus-mediated endosome disruption. 24 During the binding and internalization of the adenovirus particle by receptor-mediated endocytosis, the base of the viral penton fibers binds to the integrin v 5, which promotes the adenovirus penetration into the cytoplasm. It has been reported recently that 15 human lung cancer cell lines exhibited pronounced differences in their levels of integrin v To determine whether differences in the susceptibility to adenovirus infection could account for the observed differences in the EGF/DNA polyplex transfection efficiencies, transduction experiments using saturating amounts of an adenovirus vector containing the -gal gene were performed in the cell lines included in the EGF/DNA polyplex transfections (Table 2). The percentage of positive staining cells in this experiment directly reflects the susceptibility to adenovirus infection in each cell line. As described above, it is crucial for the intracellular release of internalized EGF/DNA polyplexes that adenovirus particles are cointernalized to mediate endosomal lysis. In our experiments, adenovirus internalization occurs through the native infection pathway independently of EGF/DNA uptake. Therefore the transduction efficiencies with Ad5CMV -gal will reflect how well adenovirus can act as an endosomolytic agent in the EGF/DNA transfections. The three cell lines CPH54A, DMS114, and DMS153 were the most susceptible to adenovirus infection, with transduction efficiencies of 94% 2.1%, 88% 1.0%, and 99% 0.5%, respectively. These cell lines were also the most efficiently transduced with polyplexes of EGF/DNA (Table 2). Furthermore, the very low susceptibility of A431 to adenovirus infection may explain why this cell line, which greatly overexpresses the EGFR, was the least susceptible to transfection with EGF/DNA polyplexes. These results suggest that sensitivity to adenovirusmediated endosomal lysis was an important determinant for the transfection efficiencies in the EGFR mediated transfections. Future vector systems for receptor-targeted gene delivery could benefit from having an intrinsic endosomolytic activity replacing the adenovirus used in the present study. The development of vector systems that can be administered in vitro and specifically hit target cells throughout the body may be decisive for the successful clinical application of gene therapy for advanced cancer. In the present study, we have demonstrated for the first time receptor-targeted gene delivery to SCLC cell lines using ligand/dna polyplexes. Furthermore, we have shown that even low EGFR expression levels are sufficient for highly efficient and specific gene delivery to SCLC cell lines through EGFR-mediated endocytosis. The importance of restricted expression of a target receptor to the target tissue has been stressed, because even low receptor expression in nontarget tissues may be sufficient for undesirable gene delivery to these tissues. Also, from the present in vitro study of EGF/DNA polyplex gene delivery, overexpression of a target receptor does not seem to be necessary for efficient gene delivery through receptor-mediated internalization. When replication-deficient adenovirus is employed as an endosomolytic agent, the sensitivity of the target cell to adenovirus infection seems to be an important determinant for the efficiency of receptor-mediated gene delivery. The EGFR is expressed in 50% of tested SCLC cell lines. 19 Complementary ligands may therefore be useful in the development of vector systems for receptortargeted gene delivery to SCLC cells. We are currently testing ligand/dna polyplexes for new candidate receptors in SCLC cell lines. Future experiments will elucidate whether these vector systems specifically can target SCLC cells in vitro and in xenotransplanted nude mice.

7 268 FREDERIKSEN, ABRAHAMSEN, CRISTIANO, ET AL: GENE DELIVERY BY AN EGF/DNA POLYPLEX TO SCLC CELL LINES ACKNOWLEDGMENTS We thank Tine V. Jensen for excellent technical assistance and Thomas Carlslund for expert help with the photographic layout. This work was supported by fabrikant Einar Willumsens mindelegat, Bristol Myers Squibb, and Danish Cancer Society Grants and REFERENCES 1. Lassen U, Østerlind K, Hansen M, et al. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18 years an analysis of 1,714 consecutive patients. J Clin Oncol. 1995;13: Wagner E, Zenke M, Cotten M, et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA. 1990;87: Gottschalk S, Cristiano RJ, Smith LC, et al. Folate receptor-mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1994;1: Wu CH, Wilson JM, Wu GY. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem. 1989;264: Cristiano RJ, Roth JA. Epidermal growth factor-mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther. 1996;3: Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51: Engelholm SA, Spang-Thomsen M, Vindeløv LL, et al. Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro, and transplanted into nude mice. Acta Pathol Microbiol Immunol Scand Sect A. 1986;94: de Leij L, Postmus PE, Buys CHCM, et al. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res. 1985;45: Pettengill OS, Sorenson GD, Wurster-Hill DH, et al. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer. 1980; 45: Pettengill OS, Cate CC, Flint CF, et al. In vitro isolation of malignant cells from small cell carcinomas. In: Pretlow TG, Pretlow TP, eds. Cell Separation: Methods and Selected Applications. New York: Academic Press; 1984: Sorenson GD, Pettengill OS, Del Prete SA, et al. Biomarkers in small cell carcinoma of the lung. In: Aisner J, ed. Lung Cancer. New York: Churchill Livingstone; 1984: Leibovitz A, Stinson JC, McCombs WB, et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36: Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51: Xu B, Wiehle S, Roth JA, Cristiano RJ. The contribution of poly-l-lysine, epidermal growth factor, and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther. 1998;5: Spitzer E, de Los Angeles M, Perez R, Grosse R. Binding properties of biotinylated epidermal growth factor to its receptor on cultured cells and tissue sections. J Cell Biochem. 1989;41: Nguyen DM, Wiehle SA, Roth JA, Cristiano RJ. Gene delivery into malignant cells in vivo by a conjugated adenovirus/dna complex. Cancer Gene Ther. 1997;4: Nguyen DM, Wiehle SA, Roth JA, Cristiano RJ. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/dna complex. Cancer Gene Ther. 1997;4: Kawamoto T, Sato JD, Le A, et al. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA. 1983;80: Damstrup L, Rygaard K, Spang-Thomsen M, et al. Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines. Cancer Res. 1992;52: MacGregor GR, Caskey CT. Construction of plasmids that express E. coli -galactosidase in mammalian cells. Nucleic Acids Res. 1989;25: Jones N, Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA. 1979;76: Haeder M, Rotsch M, Bepler G, et al. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res. 1988;48: Cristiano RJ, Smith LC, Kay MA, et al. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-dna complex. Proc Natl Acad Sci USA. 1993;90: Wickham TJ, Filardo EJ, Cheresh DA, et al. Integrin v 5 selectively promotes adenovirus-mediated cell membrane permeabilization. J Cell Biol. 1994;127: Takayama K, Ueno H, Pei X, et al. The levels of integrin v 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther. 1998;5:

Instructions for Use. APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests

Instructions for Use. APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests 3URGXFW,QIRUPDWLRQ Sigma TACS Annexin V Apoptosis Detection Kits Instructions for Use APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests For Research Use Only. Not for use in diagnostic procedures.

More information

Modulating Glucose Uptake in Skeletal Myotubes: Insulin Induction with Bioluminescent Glucose Uptake Analysis

Modulating Glucose Uptake in Skeletal Myotubes: Insulin Induction with Bioluminescent Glucose Uptake Analysis icell Skeletal Myoblasts Application Protocol Modulating Glucose Uptake in Skeletal Myotubes: Insulin Induction with Bioluminescent Glucose Uptake Analysis Introduction The skeletal muscle is one of the

More information

Validation & Assay Performance Summary

Validation & Assay Performance Summary Validation & Assay Performance Summary LanthaScreen IGF-1R GripTite Cells Cat. no. K1834 Modification Detected: Phosphorylation of Multiple Tyr Residues on IGF-1R LanthaScreen Cellular Assay Validation

More information

Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins

Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins www.vectalys.com/products/ Constitutive Reporter Lentiviral Vectors Catalog Number referring to this User Manual: 0008VCT; 0009VCT;

More information

TFEB-mediated increase in peripheral lysosomes regulates. Store Operated Calcium Entry

TFEB-mediated increase in peripheral lysosomes regulates. Store Operated Calcium Entry TFEB-mediated increase in peripheral lysosomes regulates Store Operated Calcium Entry Luigi Sbano, Massimo Bonora, Saverio Marchi, Federica Baldassari, Diego L. Medina, Andrea Ballabio, Carlotta Giorgi

More information

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze. This document is available at www.stemcell.com/pis Catalog #18765 EasySep Mouse CD4+CD62L+ T Cell Isolation Kit For processing 1x 10^9 cells Description Isolate highly purified naïve CD4+ T cells (CD4+CD62L+)

More information

Human Apolipoprotein A1 EIA Kit

Human Apolipoprotein A1 EIA Kit A helping hand for your research Product Manual Human Apolipoprotein A1 EIA Kit Catalog Number: 83901 96 assays 1 Table of Content Product Description 3 Assay Principle 3 Kit Components 3 Storage 4 Reagent

More information

MELANOMA CANCER TEST

MELANOMA CANCER TEST MELANOMA CANCER TEST Efficacy Evaluation of Antitumor Activity of Alka Vita - Alkahydroxy in the LOX-GFP Human Melanoma Model Final Report by: Anti-Cancer Lab San Diego California March 4, 2005 Efficacy

More information

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze. This document is available at www.stemcell.com/pis Catalog #18765 EasySep Mouse CD4+CD62L+ T Cell Isolation Kit For processing 1x 10^9 cells Description Isolate highly purified naïve CD4+ T cells (CD4+CD62L+)

More information

Ets-1 identifying polynucleotide sequence for targeted delivery of anti-cancer drugs

Ets-1 identifying polynucleotide sequence for targeted delivery of anti-cancer drugs Ets-1 identifying polynucleotide sequence for targeted delivery of anti-cancer drugs Indian Patent Application No. 1623/DEL/2014 Inventors: Prof. Kulbhushan Tikoo and Jasmine Kaur Department of Pharmacology

More information

The Annexin V Apoptosis Assay

The Annexin V Apoptosis Assay The Annexin V Apoptosis Assay Development of the Annexin V Apoptosis Assay: 1990 Andree at al. found that a protein, Vascular Anticoagulant α, bound to phospholipid bilayers in a calcium dependent manner.

More information

Detection of Apoptosis in Primary Cells by Annexin V Binding Using the Agilent 2100 Bioanalyzer. Application Note

Detection of Apoptosis in Primary Cells by Annexin V Binding Using the Agilent 2100 Bioanalyzer. Application Note Detection of Apoptosis in Primary Cells by Annexin V Binding Using the Agilent 2100 Bioanalyzer Application Note Samuel D. H. Chan Marc Valer and Tobias Preckel, Introduction The Agilent 2100 bioanalyzer

More information

LabBOOK VIROMER RED VIROMER YELLOW. plasmid DNA /mrna transfection

LabBOOK VIROMER RED VIROMER YELLOW. plasmid DNA /mrna transfection LabBOOK VIROMER RED VIROMER YELLOW plasmid DNA /mrna transfection General information Technology Viromer RED and Viromer YELLOW are polymer-based transfection reagents featuring a viral mechanism of membrane

More information

Tumor responses (patients responding/ patients treated)

Tumor responses (patients responding/ patients treated) Table 1. ACT clinical trial tumor responses and toxicities. a Target antigen Cancer(s) Receptor type Tumor responses (patients responding/ patients treated) Immune-mediated toxicities (patients experiencing

More information

Why chaperone vectors?

Why chaperone vectors? Why chaperone vectors? A protein folding initiative An open discussion with structural biologists Protein Structure Initiative: Pilot Phase Whether the pilot phase achieved its goal depends on how we measure

More information

Ready-to-use Lentiviral Particles for intracelular labeling

Ready-to-use Lentiviral Particles for intracelular labeling Ready-to-use Lentiviral Particles for intracelular labeling (LocLight TM Living cell imaging lentivirus for sub-cellular localization) LocLight TM cell organelle labeling lentivirus are provided as 200ul/per

More information

Citation Acta Medica Nagasakiensia. 1992, 37

Citation Acta Medica Nagasakiensia. 1992, 37 NAOSITE: Nagasaki University's Ac Title Author(s) A Study on the Expression of EGFR a Content in the Stomach Cancer Tissu Nakazaki Takayuki Citation Acta Medica Nagasakiensia. 1992 37 Issue Date 1992-12-25

More information

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

More information

Influenza A H1N1 HA ELISA Pair Set

Influenza A H1N1 HA ELISA Pair Set Influenza A H1N1 HA ELISA Pair Set for H1N1 ( A/Puerto Rico/8/1934 ) HA Catalog Number : SEK11684 To achieve the best assay results, this manual must be read carefully before using this product and the

More information

Global Histone H3 Acetylation Assay Kit

Global Histone H3 Acetylation Assay Kit Global Histone H3 Acetylation Assay Kit Catalog Number KA0633 96 assays Version: 06 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle

More information

Chemistry 106: Drugs in Society Lecture 19: How do Drugs Elicit an Effect? Interactions between Drugs and Macromolecular Targets 11/02/17

Chemistry 106: Drugs in Society Lecture 19: How do Drugs Elicit an Effect? Interactions between Drugs and Macromolecular Targets 11/02/17 Chemistry 106: Drugs in Society Lecture 19: How do Drugs Elicit an Effect? Interactions between Drugs and Macromolecular Targets 11/02/17 Targets for Therapeutic Intervention: A Comparison of Enzymes to

More information

Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1

Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 CHRISTOPH RADER, 2 MIKHAIL POPKOV, JOHN A. NEVES, AND CARLOS F. BARBAS III 2 Department of Molecular Biology and The

More information

For the 5 GATC-overhang two-oligo adaptors set up the following reactions in 96-well plate format:

For the 5 GATC-overhang two-oligo adaptors set up the following reactions in 96-well plate format: Supplementary Protocol 1. Adaptor preparation: For the 5 GATC-overhang two-oligo adaptors set up the following reactions in 96-well plate format: Per reaction X96 10X NEBuffer 2 10 µl 10 µl x 96 5 -GATC

More information

The Need for a PARP in vivo Pharmacodynamic Assay

The Need for a PARP in vivo Pharmacodynamic Assay The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D. Chief Scientific Officer Trevigen, Inc. Gaithersburg, MD Poly(ADP-ribose) polymerases are promising therapeutic targets. In response

More information

Utilizing AlphaLISA Technology to Screen for Inhibitors of the CTLA-4 Immune Checkpoint

Utilizing AlphaLISA Technology to Screen for Inhibitors of the CTLA-4 Immune Checkpoint APPLICATION NOTE AlphaLISA Technology Authors: Matthew Marunde Stephen Hurt PerkinElmer, Inc. Hopkinton, MA Utilizing AlphaLISA Technology to Screen for Inhibitors of the CTLA-4 Immune Checkpoint Introduction

More information

Gladstone Institutes, University of California (UCSF), San Francisco, USA

Gladstone Institutes, University of California (UCSF), San Francisco, USA Fluorescence-linked Antigen Quantification (FLAQ) Assay for Fast Quantification of HIV-1 p24 Gag Marianne Gesner, Mekhala Maiti, Robert Grant and Marielle Cavrois * Gladstone Institutes, University of

More information

ab CytoPainter Golgi/ER Staining Kit

ab CytoPainter Golgi/ER Staining Kit ab139485 CytoPainter Golgi/ER Staining Kit Instructions for Use Designed to detect Golgi bodies and endoplasmic reticulum by microscopy This product is for research use only and is not intended for diagnostic

More information

Sleeping Beauty: Current applications and future strategies. CAR-TCR Summit 2017 Partow Kebriaei, MD

Sleeping Beauty: Current applications and future strategies. CAR-TCR Summit 2017 Partow Kebriaei, MD Sleeping Beauty: Current applications and future strategies CAR-TCR Summit 2017 Partow Kebriaei, MD Outline Chimeric antigen receptor (CAR) technology Viral versus nonviral vectors Results of current clinical

More information

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal

More information

Islet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot

Islet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot Islet viability assay and Glucose Stimulated Insulin Secretion assay Islet cell viability was determined by colorimetric (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay using CellTiter

More information

AlphaScreen : A Straightforward and Powerful Alternative to ELISA. Martina Bielefeld-Sévigny Ph.D., R&D Director

AlphaScreen : A Straightforward and Powerful Alternative to ELISA. Martina Bielefeld-Sévigny Ph.D., R&D Director AlphaScreen : A Straightforward and Powerful Alternative to ELISA Martina Bielefeld-Sévigny Ph.D., R&D Director Overview AlphaScreen - an alternative to ELISA Why an alternative to ELISA? Assay principle

More information

TGFβR1 Kinase Inhibitor

TGFβR1 Kinase Inhibitor TGFβR1 Kinase Inhibitor Galunisertib, LY2157299 H 2 0 Prud homme GJ 1 ; Flavell RA, et al 2 Drug Discovery Platform: Cancer Angiogenesis and Tumor Microenvironment/Immuno-Oncology A Phase 1b/2 Dose-Escalation

More information

Chapter 6. Antigen Presentation to T lymphocytes

Chapter 6. Antigen Presentation to T lymphocytes Chapter 6 Antigen Presentation to T lymphocytes Generation of T-cell Receptor Ligands T cells only recognize Ags displayed on cell surfaces These Ags may be derived from pathogens that replicate within

More information

Nuclear Extraction Kit

Nuclear Extraction Kit Nuclear Extraction Kit Item No. 10009277 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION 3 Materials

More information

Adjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support

Adjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no

More information

TGFβR1 Kinase Inhibitor

TGFβR1 Kinase Inhibitor TGFβR1 Kinase Inhibitor Galunisertib, LY2157299 H 2 0 Derived from Prud homme GJ 1 ; Flavell RA, et al. 2 Drug Discovery Platform: Cancer Angiogenesis and Tumor Microenvironment/Immuno-Oncology A Phase

More information

Antigen Presentation to T lymphocytes

Antigen Presentation to T lymphocytes Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antibodies and T cell receptors

More information

Chapter 21: Prokaryotes & Viruses

Chapter 21: Prokaryotes & Viruses Chapter 21: Prokaryotes & Viruses Microorganisms Single-celled organisms that are too small to be seen without a microscope Bacteria are the smallest living organisms Viruses are smaller but are not alive

More information

Product # R8132 (Explorer Kit) R8133 (Bulk Kit)

Product # R8132 (Explorer Kit) R8133 (Bulk Kit) Product Insert QBT Fatty Acid Uptake Assay Kit Product # R8132 (Explorer Kit) R8133 (Bulk Kit) Introduction About the Fatty Acid Uptake Assay Kit The homogeneous QBT Fatty Acid Uptake Assay Kit from Molecular

More information

PREPARATION OF IF- ENRICHED CYTOSKELETAL PROTEINS

PREPARATION OF IF- ENRICHED CYTOSKELETAL PROTEINS TMM,5-2011 PREPARATION OF IF- ENRICHED CYTOSKELETAL PROTEINS Ice-cold means cooled in ice water. In order to prevent proteolysis, make sure to perform all steps on ice. Pre-cool glass homogenizers, buffers

More information

Membrane transport. Small molecules. pumps. Large molecules

Membrane transport. Small molecules. pumps. Large molecules Cell Membrane and Transport Review Sheet Transport of nutrients, ions, and excretory substances from one side to the other is a major function of the cell membrane. A number of different means have been

More information

Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions

Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions 11/20/2017 MDufilho 1 Characteristics of Viruses Viruses Minuscule, acellular, infectious agent having either DNA or RNA Cause infections

More information

TKB1 Competent Cells. Instruction Manual. Research Use Only. Not for Use in Diagnostic Procedures. Catalog # Revision B

TKB1 Competent Cells. Instruction Manual. Research Use Only. Not for Use in Diagnostic Procedures. Catalog # Revision B TKB1 Competent Cells Instruction Manual Catalog #200134 Revision B Research Use Only. Not for Use in Diagnostic Procedures. 200134-12 LIMITED PRODUCT WARRANTY This warranty limits our liability to replacement

More information

2-Deoxyglucose Assay Kit (Colorimetric)

2-Deoxyglucose Assay Kit (Colorimetric) 2-Deoxyglucose Assay Kit (Colorimetric) Catalog Number KA3753 100 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information...

More information

DELFIA Tb-DTPA ITC Chelate & Terbium Standard

DELFIA Tb-DTPA ITC Chelate & Terbium Standard AD0035P-2 (en) 1 DELFIA Tb-DTPA ITC Chelate & AD0029 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-DTPA ITC Chelate is optimized for the terbium labelling of proteins and peptides for use

More information

MagniSort Mouse CD4 T cell Enrichment Kit Catalog Number: RUO: For Research Use Only. Not for use in diagnostic procedures.

MagniSort Mouse CD4 T cell Enrichment Kit Catalog Number: RUO: For Research Use Only. Not for use in diagnostic procedures. Page 1 of 2 MagniSort Mouse CD4 T cell Enrichment Kit RUO: For Research Use Only. Not for use in diagnostic procedures. Mouse splenocytes were unsorted (left) or sorted with the MagniSort Mouse CD4 T cell

More information

CoQ10(Coenzyme Q10) ELISA Kit

CoQ10(Coenzyme Q10) ELISA Kit CoQ10(Coenzyme Q10) ELISA Kit Catalogue No.: EU0196 Size: 48T/96T Reactivity: Universal Detection Range: 0.781-50ng/ml Sensitivity:

More information

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic immunotherapy Oncolytic immunotherapy the use of a genetically modified virus to attack tumors and induce a systemic immune response

More information

MagniSort Mouse CD4 Naive T cell Enrichment Kit Catalog Number: RUO: For Research Use Only. Not for use in diagnostic procedures.

MagniSort Mouse CD4 Naive T cell Enrichment Kit Catalog Number: RUO: For Research Use Only. Not for use in diagnostic procedures. Page 1 of 2 MagniSort Mouse CD4 Naive T cell Enrichment Kit RUO: For Research Use Only. Not for use in diagnostic procedures. Mouse splenocytes were unsorted (left) or sorted with the MagniSort Mouse CD4

More information

Effect of a Selenium Analogue of [L Title Transport of Candida pelliculosa (C Dedicated to Professor Masaya Okano Retirement) Author(s) Shimizu, Eiichi; Yamana, Ryutaro; T Kenji Citation Bulletin of the

More information

Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535

Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535 Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535 Product Description Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive

More information

EPIGENTEK. EpiQuik Global Histone H4 Acetylation Assay Kit. Base Catalog # P-4009 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik Global Histone H4 Acetylation Assay Kit. Base Catalog # P-4009 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik Global Histone H4 Acetylation Assay Kit Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Global Histone H4 Acetylation Assay Kit is suitable for specifically measuring global

More information

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS)

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS) Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS) and their exosomes (EXO) in resting (REST) and activated

More information

ADCC Assay Protocol Vikram Srivastava 1, Zheng Yang 1, Ivan Fan Ngai Hung 2, Jianqing Xu 3, Bojian Zheng 3 and Mei- Yun Zhang 3*

ADCC Assay Protocol Vikram Srivastava 1, Zheng Yang 1, Ivan Fan Ngai Hung 2, Jianqing Xu 3, Bojian Zheng 3 and Mei- Yun Zhang 3* ADCC Assay Protocol Vikram Srivastava 1, Zheng Yang 1, Ivan Fan Ngai Hung 2, Jianqing Xu 3, Bojian Zheng 3 and Mei- Yun Zhang 3* 1 Department of Microbiology, Li Ka Shing Faculty of Medicine, University

More information

Human Mammary Luminal Epithelial Cells. Manual

Human Mammary Luminal Epithelial Cells. Manual Human Mammary Luminal Epithelial Cell Manual INSTRUCTION MANUAL SHIPPING CONDITIONS ZBM0071.00 Human Mammary Luminal Epithelial Cells Orders are delivered via Federal Express courier. All US and Canada

More information

Corning BioCoat Matrigel Invasion Chamber

Corning BioCoat Matrigel Invasion Chamber Corning BioCoat Matrigel Invasion Chamber Catalog No. 354480, 354481 Guidelines for Use Discovery Labware, Inc., Two Oak Park, Bedford, MA 01730, Tel: 1.978.442.2200 (U.S.) CLSTechServ@Corning.com www.corning.com/lifesciences

More information

Erzsebet Kokovay, Susan Goderie, Yue Wang, Steve Lotz, Gang Lin, Yu Sun, Badrinath Roysam, Qin Shen,

Erzsebet Kokovay, Susan Goderie, Yue Wang, Steve Lotz, Gang Lin, Yu Sun, Badrinath Roysam, Qin Shen, Cell Stem Cell, Volume 7 Supplemental Information Adult SVZ Lineage Cells Home to and Leave the Vascular Niche via Differential Responses to SDF1/CXCR4 Signaling Erzsebet Kokovay, Susan Goderie, Yue Wang,

More information

Pharmacodynamics. OUTLINE Definition. Mechanisms of drug action. Receptors. Agonists. Types. Types Locations Effects. Definition

Pharmacodynamics. OUTLINE Definition. Mechanisms of drug action. Receptors. Agonists. Types. Types Locations Effects. Definition Pharmacodynamics OUTLINE Definition. Mechanisms of drug action. Receptors Types Locations Effects Agonists Definition Types Outlines of Pharmacodynamics Antagonists Definition Types Therapeutic Index Definition

More information

Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZO Food Research, The Netherlands

Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZO Food Research, The Netherlands Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZ Food Research, The Netherlands René Floris has studied chemistry at Leiden University and obtained his PhD degree

More information

Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535

Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535 Data Sheet PD-1 / NFAT Reporter - Jurkat Cell Line Catalog #: 60535 Product Description Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive

More information

Supplemental Figure 1. Cell-bound Cetuximab reduces EGFR staining intensity. Blood

Supplemental Figure 1. Cell-bound Cetuximab reduces EGFR staining intensity. Blood Antibody-mediated depletion of CD19-CAR T cells Supplemental 1 Supplemental Materials Supplemental Figure 1. Supplemental Figure 1. Cell-bound Cetuximab reduces EGFR staining intensity. Blood cells were

More information

LH (Bovine) ELISA Kit

LH (Bovine) ELISA Kit LH (Bovine) ELISA Kit Catalog Number KA2280 96 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...

More information

Thyroxine (T4) Human ELISA Kit

Thyroxine (T4) Human ELISA Kit ab108662 Thyroxine (T4) Human ELISA Kit Instructions for Use For the quantitative measurement of Human Thyroxine (T4) concentrations in serum. This product is for research use only and is not intended

More information

Pre-made Lentiviral Particles for Fluorescent Proteins

Pre-made Lentiviral Particles for Fluorescent Proteins Pre-made Lentiviral Particles for Fluorescent Proteins Catalog# Product Name Amounts Fluorescent proteins expressed under sucmv promoter: LVP001 LVP001-PBS LVP002 LVP002-PBS LVP011 LVP011-PBS LVP012 LVP012-PBS

More information

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set Catalog Number : SEK002 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

More information

THE ROLE OF ALTERED CALCIUM AND mtor SIGNALING IN THE PATHOGENESIS OF CYSTINOSIS

THE ROLE OF ALTERED CALCIUM AND mtor SIGNALING IN THE PATHOGENESIS OF CYSTINOSIS Research Foundation, 18 month progress report THE ROLE OF ALTERED CALCIUM AND mtor SIGNALING IN THE PATHOGENESIS OF CYSTINOSIS Ekaterina Ivanova, doctoral student Elena Levtchenko, MD, PhD, PI Antonella

More information

oncogenes-and- tumour-suppressor-genes)

oncogenes-and- tumour-suppressor-genes) Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging

More information

EPIGENTEK. EpiQuik HDAC2 Assay Kit (Colorimetric) Base Catalog # P-4006 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik HDAC2 Assay Kit (Colorimetric) Base Catalog # P-4006 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik HDAC2 Assay Kit (Colorimetric) Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik HDAC2 Assay Kit is very suitable for measuring HDAC2 levels from various fresh tissues and

More information

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze. This document is available at www.stemcell.com/pis EasySep Mouse Monocyte Isolation Kit Catalog #19861 For processing 1 x 10^9 cells Description Isolate untouched and highly purified monocytes from mouse

More information

Lipid Peroxidation Assay

Lipid Peroxidation Assay Package Insert Lipid Peroxidation Assay 96 Wells For Research Use Only v. 1.0 Eagle Biosciences, Inc. 82 Broad Street, Suite 383, Boston, MA 02110 Phone: 866-419-2019 Fax: 617-419-1110 INTRODUCTION Lipid

More information

Application Note. Introduction

Application Note. Introduction Simultaneously Measuring Oxidation of Exogenous and Endogenous Fatty Acids Using the XF Palmitate-BSA FAO Substrate with the Agilent Seahorse XF Cell Mito Stress Test Application Note Introduction The

More information

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay

More information

Blocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro

Blocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro Blocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro Y.-B. Deng, H.-J. Qin, Y.-H. Luo, Z.-R. Liang and J.-J. Zou

More information

RayBio Human PPAR-alpha Transcription Factor Activity Assay Kit

RayBio Human PPAR-alpha Transcription Factor Activity Assay Kit RayBio Human PPAR-alpha Transcription Factor Activity Assay Kit Catalog #: TFEH-PPARa User Manual Jan 5, 2018 3607 Parkway Lane, Suite 200 Norcross, GA 30092 Tel: 1-888-494-8555 (Toll Free) or 770-729-2992,

More information

Cancer Immunotherapy: Active Immunization Approaches

Cancer Immunotherapy: Active Immunization Approaches Cancer Immunotherapy: Active Immunization Approaches Willem W. Overwijk, PhD Department of Melanoma Medical Oncology MD Anderson Cancer Center Houston, TX, USA Disclosures No relevant financial relationships

More information

Midi Plant Genomic DNA Purification Kit

Midi Plant Genomic DNA Purification Kit Midi Plant Genomic DNA Purification Kit Cat #:DP022MD/ DP022MD-50 Size:10/50 reactions Store at RT For research use only 1 Description: The Midi Plant Genomic DNA Purification Kit provides a rapid, simple

More information

DELFIA Eu-DTPA ITC Chelate & Europium Standard

DELFIA Eu-DTPA ITC Chelate & Europium Standard AD0026P-3 (en) 1 DELFIA Eu-DTPA ITC Chelate & AD0021 Europium Standard For Research Use Only INTRODUCTION DELFIA Eu-DTPA ITC Chelate is optimized for the europium labelling of proteins and peptides for

More information

ab LDL Uptake Assay Kit (Cell-Based)

ab LDL Uptake Assay Kit (Cell-Based) ab133127 LDL Uptake Assay Kit (Cell-Based) Instructions for Use For the detection of LDL uptake into cultured cells. This product is for research use only and is not intended for diagnostic use. Version

More information

2013 W. H. Freeman and Company. 12 Signal Transduction

2013 W. H. Freeman and Company. 12 Signal Transduction 2013 W. H. Freeman and Company 12 Signal Transduction CHAPTER 12 Signal Transduction Key topics: General features of signal transduction Structure and function of G protein coupled receptors Structure

More information

Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles

Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles Amin Feizpour Reinhard Lab Department of Chemistry and the Photonics Center, Boston University, Boston, MA May 2014

More information

microrna Presented for: Presented by: Date:

microrna Presented for: Presented by: Date: microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions

More information

Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells

Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells Proc. Natl. Acad. Sci. USA Vol. 73, No. 7, pp. 2434-2438, July 1976 Cell Biology Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells

More information

Bioactivity Assays: Putting the Puzzle Together

Bioactivity Assays: Putting the Puzzle Together Bioactivity Assays: Putting the Puzzle Together Dr. Ulrike Herbrand Department for Biosafety & Bioassay Services Charles River Biologics Testing Solutions Outline General Remarks MoA reflecting bioassays

More information

DEVELOPMENTAL VALIDATION OF SPERM HY-LITER EXPRESS Jennifer Old, Chris Martersteck, Anna Kalinina, Independent Forensics, Lombard IL

DEVELOPMENTAL VALIDATION OF SPERM HY-LITER EXPRESS Jennifer Old, Chris Martersteck, Anna Kalinina, Independent Forensics, Lombard IL DEVELOPMENTAL VALIDATION OF SPERM HY-LITER EXPRESS Jennifer Old, Chris Martersteck, Anna Kalinina, Independent Forensics, Lombard IL Background and Introduction SPERM HY-LITER is the first immunofluorescent

More information

Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION

Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION X. Shawn Liu 1, 3, Bing Song 2, 3, Bennett D. Elzey 3, 4, Timothy L. Ratliff 3, 4, Stephen F. Konieczny

More information

UNIVERSITY OF GUELPH CHEM 4540 ENZYMOLOGY Winter 2005 Quiz #2: March 24, 2005, 11:30 12:50 Instructor: Prof R. Merrill ANSWERS

UNIVERSITY OF GUELPH CHEM 4540 ENZYMOLOGY Winter 2005 Quiz #2: March 24, 2005, 11:30 12:50 Instructor: Prof R. Merrill ANSWERS UNIVERSITY F GUELPH CHEM 4540 ENZYMLGY Winter 2005 Quiz #2: March 24, 2005, 11:30 12:50 Instructor: Prof R. Merrill ANSWERS Instructions: Time allowed = 80 minutes. Total marks = 30. This quiz represents

More information

Auxin-Inducible Degron (AID) System Total Set

Auxin-Inducible Degron (AID) System Total Set Catalog No. BRS-APC011A Auxin-Inducible Degron (AID) System Total Set This AID System Charactoristics Principle of Auxin-Inducible Degron (AID ) System AID plasmid protein 1. Transfection of AID plasmid

More information

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit 2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as

More information

Immune surveillance hypothesis (Macfarlane Burnet, 1950s)

Immune surveillance hypothesis (Macfarlane Burnet, 1950s) TUMOR-IMMUNITÄT A.K. Abbas, A.H. Lichtman, S. Pillai (6th edition, 2007) Cellular and Molecular Immunology Saunders Elsevier Chapter 17, immunity to tumors Immune surveillance hypothesis (Macfarlane Burnet,

More information

EGFR (py1045)/ Pan EGFR (Human) ELISA Kit

EGFR (py1045)/ Pan EGFR (Human) ELISA Kit EGFR (py1045)/ Pan EGFR (Human) ELISA Kit Catalog Number KA2156 96 assays Version: 01 Intended for research use only www.abnova.com I. INTRODUCTION EGFR (py1045)/pan EGFR (Human) ELISA (Enzyme-Linked Immunosorbent

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer

More information

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk 1 Virus-Receptor Interactions BERNARD N. FIELDS Department of Microbiology and Molecular Genetics, Harvard Medical School, and Department of Medicine (Infectious Disease), Brigham and Women's Hospital,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:1.138/nature9814 a A SHARPIN FL B SHARPIN ΔNZF C SHARPIN T38L, F39V b His-SHARPIN FL -1xUb -2xUb -4xUb α-his c Linear 4xUb -SHARPIN FL -SHARPIN TF_LV -SHARPINΔNZF -SHARPIN

More information

Rational combinations with immunotherapeutics

Rational combinations with immunotherapeutics Rational combinations with immunotherapeutics Ronald Levy, MD Robert K. and Helen K. Summy Professor of Medicine Director, Lymphoma Program Stanford University School of Medicine Associate Director, Translational

More information

NF-κB p65 (Phospho-Thr254)

NF-κB p65 (Phospho-Thr254) Assay Biotechnology Company www.assaybiotech.com Tel: 1-877-883-7988 Fax: 1-877-610-9758 NF-κB p65 (Phospho-Thr254) Colorimetric Cell-Based ELISA Kit Catalog #: OKAG02015 Please read the provided manual

More information

Enzymes: The Catalysts of Life

Enzymes: The Catalysts of Life Chapter 6 Enzymes: The Catalysts of Life Lectures by Kathleen Fitzpatrick Simon Fraser University Activation Energy and the Metastable State Many thermodynamically feasible reactions in a cell that could

More information

ab E3 Ligase Auto- Ubiquitilylation Assay Kit

ab E3 Ligase Auto- Ubiquitilylation Assay Kit ab139469 E3 Ligase Auto- Ubiquitilylation Assay Kit Instructions for Use For testing ubiquitin E3 ligase activity through assessment of their ability to undergo auto-ubiquitinylation This product is for

More information

Disclosures: A.G. Bajpayee: None. A.M. Scheu: None. R.M. Porter: None. A.J. Grodzinsky: None.

Disclosures: A.G. Bajpayee: None. A.M. Scheu: None. R.M. Porter: None. A.J. Grodzinsky: None. Avidin as a Carrier for Drug Delivery into Cartilage: Electrostatic Interactions Enable Rapid Penetration, Enhanced Uptake, and Retention in Rat Knee Joints Ambika Goel Bajpayee 1, Alfredo M. Scheu 2,

More information